135 related articles for article (PubMed ID: 1699673)
1. Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development.
Bouwer HG; Dietsch GN; Hinrichs DJ
Cell Immunol; 1990 Nov; 131(1):219-31. PubMed ID: 1699673
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
Bouwer HG; Hinrichs DJ
J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
[TBL] [Abstract][Full Text] [Related]
3. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
Bouwer HG; Hinrichs DJ
J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
[TBL] [Abstract][Full Text] [Related]
4. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
Wegmann KW; Hinrichs DJ
J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
[TBL] [Abstract][Full Text] [Related]
5. T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis.
Volovitz I; Mor F; Machlenkin A; Goldberger O; Marmor Y; Eisenbach L; Cohen IR
Immunology; 2009 Sep; 128(1):92-102. PubMed ID: 19689739
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease.
Sun D; Whitaker JN; Wilson DB
Int Immunol; 1999 Mar; 11(3):307-15. PubMed ID: 10221642
[TBL] [Abstract][Full Text] [Related]
7. LPS augments adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
Hamada T; Driscoll BF; Kies MW; Alvord EC
Autoimmunity; 1989; 2(4):275-84. PubMed ID: 2485079
[TBL] [Abstract][Full Text] [Related]
8. Absence of the memory response to encephalitogen following intergender adoptively transferred experimental autoimmune encephalomyelitis.
Archie Bouwer HG; Gregory CR; Wegmann KW; Hinrichs DJ
J Neuroimmunol; 2015 Jan; 278():194-9. PubMed ID: 25468271
[TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental allergic encephalomyelitis in Lewis rats by administration of gangliosides.
Shimada K; Koh CS; Uemura K; Yanagisawa N
Cell Immunol; 1994 Mar; 154(1):231-9. PubMed ID: 7509729
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune effector cells. VIII. Cellular requirements for the induction of autoreactive T cells of experimental allergic encephalomyelitis in nonimmune rats.
Silberg DG; Swanborg RH
J Immunol; 1986 Apr; 136(7):2432-6. PubMed ID: 3485150
[TBL] [Abstract][Full Text] [Related]
12. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
Bolton C; Allsopp G; Cuzner ML
Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
[TBL] [Abstract][Full Text] [Related]
13. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
Dasgupta S; Zhou Y; Jana M; Banik NL; Pahan K
J Immunol; 2003 Apr; 170(7):3874-82. PubMed ID: 12646656
[TBL] [Abstract][Full Text] [Related]
14. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
Waxman FJ; Taguiam JM; Whitacre CC
Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune encephalomyelitis mediated by T-cell line. II. Specific requirements and the role of pertussis vaccine for the in vitro activation of the cells and induction of disease.
Lando Z; Ben-Nun A
Clin Immunol Immunopathol; 1984 Feb; 30(2):290-303. PubMed ID: 6198119
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune effector cells. VII. Cells isolated from thymus and spinal cord of rats with experimental allergic encephalomyelitis transfer disease.
Hayosh NS; Swanborg RH
Am J Pathol; 1986 Feb; 122(2):218-22. PubMed ID: 2418687
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
19. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
Vandenbark AA; Gill T; Offner H
J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis.
Willenborg DO; Sjollema P; Danta G
J Neuroimmunol; 1986 Apr; 11(2):93-103. PubMed ID: 2419359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
